Member Workstream 2

Mira Katan Kahles studied medicine at the University of Zurich, where she received her MD in 2006. She completed her neurology training at University Hospital Basel, followed by advanced clinical and scientific training in the United States, including a fellowship at Columbia University in New York and a Master’s degree in Biostatistics and Epidemiology. After returning to Switzerland, she obtained her habilitation at the University of Zurich and subsequently returned to University Hospital Basel.

Her scientific focus lies in neurological and neurovascular diseases, with a particular emphasis on biomarker-based precision medicine. Her research integrates molecular characterization, clinical phenotyping, and population-based analyses to identify disease-specific biological signatures and to define their prognostic value and relevance for therapeutic stratification.

With this appointment, Prof. Katan Kahles strengthens the University of Basel’s profile in clinical and translational neurosciences and contributes to its international visibility in research, teaching, and highly specialized neurological care.